I have been following the Myelin Research Foundation since its inception (just about the time I was diagnosed). When I was diagnosed, the neuro (and a second opined neuro), told me that the interferon drugs would not help me - the MS was inactive and would probably not flare because of my age
. They did tell me the degeneration would probably continue, so I should hope for a drug to repair the damage. Hence, my interest with the MRF.
I was impressed with the game plan, the strategic target and the timeline. As a CEO, I know how difficult it is to meet and to exceed the original endpoints. MRF has brought together a synergy of dedicated doctors and researchers. And, yes, they have to bring in the big pharmas to get the stuff to market. But, remember they are negotiating with Scott Johnson - I am glad he is on our side.